Emily Schirmer

Emily Schirmer is an accomplished professional in chemical engineering with extensive experience in process development for biopharmaceuticals. Currently serving as General Manager at Catalent Pharma Solutions since March 2015, Schirmer has held various leadership roles, including Senior Director Process Development and Director of Downstream Process Development. Prior experience includes positions at Epicentre, Eleven Biotherapeutics, and Percivia, LLC, where notable contributions involved the development of downstream processes for recombinant proteins and monoclonal antibodies. Academic background includes a PhD and MS in Chemical Engineering from the University of Virginia, where research focused on protein transport in chromatographic separations, alongside teaching assistant roles furthering education in the field.